Liver and Kidney Magnetic Resonance Elastography Study

Overview

About this study

The purpose of this research is to use advanced 3D kidney MRE imaging for detecting or characterizing hepatorenal syndrome processes, providing capabilities unavailable with other imaging techniques or serum biomarkers.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Primary liver diseases.
  • Diagnosis of suspected kidney function insufficient with laboratory test.
  • Age ≥ 18 years.

Exclusion Criteria: 

  • Patients with kidney congenital diseases, such as renal agenesis, hypoplasia, horseshoe kidney, abnormal location kidney, etc.
  • Patients with transplant kidney.
  • Patients with HIV infection (lower immune activity).
  • History of liver transplantation or hepatic resection.
  • Absolute contraindications to MRI including pacemaker, AICD device, cochlear implant, VP shunt, aneurysm clip, a deep brain stimulator, and severe claustrophobia.
  • Women who are pregnant or breastfeeding.
  • Any severe medical condition that, in the opinion of the Principal Investigator, would serve as exclusion criteria for study enrollment.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Meng Yin, Ph.D.

Open for enrollment

Contact information:

Meng Yin Ph.D.

(507) 284-9777

Yin.Meng@mayo.edu

More information

Publications

Publications are currently not available